Published January 24, 2023 | Version v1
Journal article Open

RISK-BENEFIT PROFILE OF AZITHROMYCIN: A BRIEF REVIEW

Description

Introduction: The most commonly given antibacterial drug worldwide is azithromycin. It belongs to the group of antibiotics known as macrolides. It is typically utilized in upper and lower respiratory tract infections,some sexually transmitted diseases,and severe bacterial infections due to its increased efficacy,tolerance,and broad-spectrum activity.Methods:Articles from the literature were examined to learn more about the risks and advantages of azithromycin. Results : Due to its low incidence of side effects, this is often marketed in solid, liquid, and ophthalmic formulations.Owing to its pharmacological and therapeutic qualities,it is also employed in the medication therapy for COVID-19. Conclusions: According to a review of the literature,there may be a higher risk of cardiac mortality, liver damage, ototoxicity, and hypersensitivity reactions.

Keywords: Macrolides, Antibiotics, Azithromycin,QT prolongation,Ototoxicity

Files

50.Rispa Mariyam Raju Azithromycin-review (1).pdf

Files (654.3 kB)

Name Size Download all
md5:224b03950b5e1e64119072e00f80161e
654.3 kB Preview Download